B-cell depletion is protective against anti-AAV capsid immune response: a human subject case study

Cited by papers we hold 6

• Successes and challenges in clinical gene therapy · 2023
  No notice
• Current Clinical Applications of In Vivo Gene Therapy with AAVs · 2021
  No notice
• The once and future gene therapy · 2020
  No notice
• Rescuing AAV gene transfer from neutralizing antibodies with an IgG-degrading enzyme · 2020
  No notice
• Human Immune Responses to Adeno-Associated Virus (AAV) Vectors · 2020
  No notice
• Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration · 2018
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.